SGRY
Surgery Partners, Inc. NASDAQ Listed Sep 30, 2015$14.30
Mkt Cap $1.9B
52w Low $11.41
22.6% of range
52w High $24.18
50d MA $13.36
200d MA $17.54
P/E (TTM)
-23.4x
EV/EBITDA
10.2x
P/B
0.5x
Debt/Equity
2.4x
ROE
-4.5%
P/FCF
10.0x
RSI (14)
—
ATR (14)
—
Beta
1.99
50d MA
$13.36
200d MA
$17.54
Avg Volume
1.6M
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
310 Seven Springs Way · Brentwood, TN 37027 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | BMO | 0.31 | 0.12 | -61.3% | 15.88 | -21.9% | -12.3% | +0.0% | +1.1% | +0.2% | -5.3% | — |
| Nov 10, 2025 | BMO | 0.19 | 0.13 | -31.6% | 16.04 | +0.9% | -1.8% | +0.0% | +0.7% | -3.5% | -0.2% | — |
| Aug 5, 2025 | BMO | 0.16 | 0.17 | +6.2% | 22.14 | -0.8% | +1.2% | +0.0% | +3.6% | +1.8% | -3.8% | — |
| May 12, 2025 | BMO | 0.08 | 0.04 | -50.0% | 23.26 | +0.1% | -1.4% | +0.0% | -0.7% | +3.8% | +1.3% | — |
| Mar 3, 2025 | BMO | 0.38 | 0.44 | +15.8% | 24.00 | -0.4% | -0.8% | +0.0% | +0.7% | +0.8% | -0.5% | — |
| Nov 12, 2024 | BMO | 0.25 | 0.19 | -24.0% | 29.57 | +1.8% | -13.7% | +0.0% | -2.9% | -7.3% | -4.9% | — |
| Aug 6, 2024 | BMO | 0.21 | 0.21 | +0.0% | 29.64 | -1.7% | -3.5% | +0.0% | +4.8% | -0.8% | -2.2% | — |
| May 7, 2024 | BMO | 0.07 | 0.10 | +42.9% | 27.77 | -2.6% | -2.2% | +0.0% | -0.3% | -1.8% | -2.7% | — |
| Feb 26, 2024 | BMO | 0.37 | 0.44 | +18.9% | 30.20 | +1.6% | +5.4% | +0.0% | -2.1% | -0.5% | +0.5% | — |
| Nov 7, 2023 | BMO | 0.14 | 0.19 | +35.7% | 28.28 | -0.2% | -3.2% | +0.0% | -6.4% | +2.2% | +2.0% | — |
| Aug 1, 2023 | BMO | 0.07 | 0.28 | +300.0% | 36.94 | +0.0% | +0.4% | +0.0% | -0.2% | -0.4% | +1.1% | — |
| May 1, 2023 | BMO | 0.00 | 0.08 | +1951.3% | 39.37 | +4.1% | -5.6% | +0.0% | -1.0% | -5.6% | +1.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5 | UBS | Maintains | Buy → Buy | — | $14.08 | $13.88 | -1.4% | +0.2% | -5.3% | -0.4% | -2.6% | +4.1% |
| Mar 5 | TD Cowen | Maintains | Buy → Buy | — | $14.08 | $13.88 | -1.4% | +0.2% | -5.3% | -0.4% | -2.6% | +4.1% |
| Mar 5 | Mizuho | Maintains | Outperform → Outperform | — | $14.08 | $13.88 | -1.4% | +0.2% | -5.3% | -0.4% | -2.6% | +4.1% |
| Mar 4 | RBC Capital | Maintains | Outperform → Outperform | — | $13.92 | $13.84 | -0.6% | +1.1% | +0.2% | -5.3% | -0.4% | -2.6% |
| Mar 3 | Barclays | Maintains | Equal Weight → Equal Weight | — | $15.88 | $12.41 | -21.9% | -12.3% | +1.1% | +0.2% | -5.3% | -0.4% |
| Dec 18 | Mizuho | Maintains | Outperform → Outperform | — | $15.80 | $15.90 | +0.6% | +0.2% | -0.8% | +0.0% | -1.1% | +0.6% |
| Nov 24 | JP Morgan | Maintains | Neutral → Neutral | — | $15.84 | $15.89 | +0.3% | +2.8% | +3.7% | +1.0% | +0.1% | +0.2% |
| Nov 21 | Barclays | Maintains | Equal Weight → Equal Weight | — | $15.30 | $15.23 | -0.5% | +3.5% | +2.8% | +3.7% | +1.0% | +0.1% |
| Nov 17 | Mizuho | Maintains | Outperform → Outperform | — | $15.28 | $15.33 | +0.3% | -1.4% | +0.8% | +3.5% | -2.6% | +3.5% |
| Nov 13 | UBS | Maintains | Buy → Buy | — | $15.86 | $15.70 | -1.0% | -3.5% | -0.2% | -1.4% | +0.8% | +3.5% |
| Nov 11 | RBC Capital | Maintains | Outperform → Outperform | — | $16.04 | $16.18 | +0.9% | -1.8% | +0.7% | -3.5% | -0.2% | -1.4% |
| Nov 11 | Benchmark | Maintains | Buy → Buy | — | $16.04 | $16.18 | +0.9% | -1.8% | +0.7% | -3.5% | -0.2% | -1.4% |
| Oct 7 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $20.39 | $20.30 | -0.4% | +0.0% | +1.0% | -1.3% | -2.9% | +0.3% |
| May 27 | Barclays | Maintains | Equal Weight → Equal Weight | — | $22.80 | $22.94 | +0.6% | +1.1% | -0.7% | -0.4% | +3.6% | -0.9% |
| Apr 21 | Benchmark | Maintains | Buy → Buy | — | $21.22 | $20.95 | -1.3% | -4.8% | +1.5% | +3.4% | +3.0% | -1.6% |
| Mar 25 | RBC Capital | Maintains | Outperform → Outperform | — | $24.39 | $24.47 | +0.3% | -0.8% | -0.7% | +0.4% | -0.7% | -0.8% |
| Mar 11 | Macquarie | Maintains | Outperform → Outperform | — | $23.66 | $23.66 | +0.0% | -0.1% | -1.0% | +0.9% | -0.0% | +3.4% |
| Dec 3 | JP Morgan | Maintains | Neutral → Neutral | — | $23.81 | $23.72 | -0.4% | -3.4% | -2.1% | -4.7% | +2.0% | +1.6% |
| Nov 20 | RBC Capital | Maintains | Outperform → Outperform | — | $22.75 | $22.56 | -0.8% | -1.1% | +3.7% | -1.5% | +1.7% | -2.1% |
| Nov 19 | Macquarie | Maintains | Outperform → Outperform | — | $21.83 | $21.66 | -0.8% | +4.2% | -1.1% | +3.7% | -1.5% | +1.7% |
| Nov 13 | Macquarie | Maintains | Outperform → Outperform | — | $29.57 | $30.11 | +1.8% | -13.7% | -2.9% | -7.3% | -4.9% | +4.2% |
| Nov 4 | Macquarie | Maintains | Outperform → Outperform | — | $28.75 | $28.79 | +0.1% | +1.6% | +1.7% | -1.3% | +3.7% | -0.2% |
| Oct 4 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $31.19 | $31.63 | +1.4% | -0.1% | -3.4% | -1.8% | +0.4% | +2.2% |
| Aug 26 | Benchmark | Maintains | Buy → Buy | — | $33.69 | $33.70 | +0.0% | -3.5% | -0.0% | -1.5% | -1.8% | +1.7% |
| Aug 20 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $28.62 | $28.55 | -0.2% | -2.7% | +0.3% | +2.5% | +17.6% | -3.5% |
| Aug 19 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $29.02 | $29.12 | +0.3% | -1.4% | -2.7% | +0.3% | +2.5% | +17.6% |
| Aug 7 | Benchmark | Maintains | Buy → Buy | — | $29.64 | $29.15 | -1.7% | -3.5% | +4.8% | -0.8% | -2.2% | +3.1% |
| Aug 7 | Citigroup | Maintains | Buy → Buy | — | $29.64 | $29.15 | -1.7% | -3.5% | +4.8% | -0.8% | -2.2% | +3.1% |
| Aug 7 | RBC Capital | Maintains | Outperform → Outperform | — | $29.64 | $29.15 | -1.7% | -3.5% | +4.8% | -0.8% | -2.2% | +3.1% |
| Jul 10 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $24.06 | $24.24 | +0.7% | -2.3% | +8.7% | +5.2% | -4.2% | +8.1% |
| Jul 9 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $23.08 | $22.99 | -0.4% | +4.2% | -2.3% | +8.7% | +5.2% | -4.2% |
| Jul 2 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $23.41 | $23.59 | +0.8% | +1.3% | -0.5% | -0.8% | -1.4% | +4.2% |
| May 8 | Citigroup | Maintains | Buy → Buy | — | $27.77 | $27.05 | -2.6% | -2.2% | -0.3% | -1.8% | -2.7% | +4.2% |
| May 1 | Benchmark | Maintains | Buy → Buy | — | $24.95 | $24.88 | -0.3% | -1.3% | +1.5% | -1.9% | +4.4% | +8.5% |
| Apr 10 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $27.59 | $26.53 | -3.8% | -4.8% | -1.2% | +1.5% | -2.5% | -3.7% |
| Mar 5 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $30.50 | $30.31 | -0.6% | +0.0% | +1.0% | -2.6% | -1.7% | +0.3% |
| Feb 29 | RBC Capital | Maintains | Outperform → Outperform | — | $31.18 | $31.71 | +1.7% | -0.5% | +0.5% | -2.2% | +0.0% | +1.0% |
| Feb 27 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $30.20 | $30.68 | +1.6% | +5.4% | -2.1% | -0.5% | +0.5% | -2.2% |
| Feb 27 | Citigroup | Maintains | Buy → Buy | — | $30.20 | $30.68 | +1.6% | +5.4% | -2.1% | -0.5% | +0.5% | -2.2% |
| Nov 14 | TD Cowen | Upgrade | Market Perform → Outperform | — | $26.70 | $28.83 | +8.0% | +13.0% | +3.0% | -0.9% | +4.7% | -0.4% |
| Oct 12 | Benchmark | Maintains | Buy → Buy | — | $25.76 | $25.74 | -0.1% | -8.6% | -0.0% | +1.5% | +6.2% | -1.1% |
| Sep 14 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $32.20 | $32.51 | +1.0% | -0.1% | -3.0% | +0.5% | -3.2% | +0.8% |
| Aug 2 | Barclays | Maintains | Overweight → Overweight | — | $36.94 | $36.94 | +0.0% | +0.4% | -0.2% | -0.4% | +1.1% | -4.2% |
| Aug 2 | Benchmark | Maintains | Buy → Buy | — | $36.94 | $36.94 | +0.0% | +0.4% | -0.2% | -0.4% | +1.1% | -4.2% |
| Jul 31 | Benchmark | Maintains | Buy → Buy | — | $38.18 | $38.31 | +0.3% | +1.2% | -4.4% | +0.4% | -0.2% | -0.4% |
| Jul 11 | Mizuho | Maintains | Buy → Buy | — | $43.44 | $43.88 | +1.0% | -1.1% | +2.2% | +1.4% | -1.1% | -0.0% |
| Jun 2 | BofA Securities | Upgrade | Neutral → Buy | — | $38.16 | $39.96 | +4.7% | +4.2% | -2.2% | -0.1% | -0.5% | +2.4% |
| May 12 | Mizuho | Maintains | Buy → Buy | — | $35.18 | $35.60 | +1.2% | +0.5% | +2.1% | -1.2% | +2.8% | +0.8% |
| May 2 | Citigroup | Maintains | Buy → Buy | — | $39.37 | $41.00 | +4.1% | -5.6% | -1.0% | -5.6% | +1.4% | -0.4% |
| May 2 | Benchmark | Maintains | Buy → Buy | — | $39.37 | $41.00 | +4.1% | -5.6% | -1.0% | -5.6% | +1.4% | -0.4% |
No insider trades available.
8-K · 2.02
!! High
Surgery Partners, Inc. -- 8-K 2.02: Earnings Results
Surgery Partners reported Q1 2026 earnings results, providing investors with updated financial performance metrics and operational updates for the first quarter.
May 5
8-K · 7.01
! Medium
Surgery Partners, Inc. -- 8-K 7.01: Regulation FD Disclosure
Surgery Partners (SGRY) will host a conference call on March 3, 2026 to discuss its full-year and fourth-quarter 2025 financial results.
Mar 2
Data updated apr 27, 2026 1:02am
· Source: massive.com